Virginia Medicaid PDL/CCF and 90-Day Supply List Changes, FDA Approval of OTC Naloxone, and DUR Board Approved Drug SAs
The purpose of this memorandum is to notify providers about updates to the Virginia Medicaid’s fee-for-service (FFS) Preferred Drug List (PDL) Program, 90-day supply list, naloxone FDA approval status, and drug service authorization (SA) requirements for drugs reviewed by the Department’s Pharmacy and Therapeutics Committee (P&T) and the Drug Utilization Review (DUR) Board.
